Tag: Lonza
Lonza Continues Investment in China with New Manufacturing Services Facility...
Lonza, a global contract development and manufacturing organization (CDMO), in a statement, said that it will invest to establish drug product manufacturing capabilities at...
Lonza Expands its Bioconjugation Facility with Two Additional Manufacturing Suites and...
Lonza is expanding its bioconjugation capabilities at its Visp in Switzerland. The expansion adds two production suites to the existing conjugation facility providing development...
Lonza to Provide Customer-Dedicated Suites for Commercialization of Bioconjugates
Lonza, in a statement, confirmed signing a strategic collaboration for bioconjugation with a global biopharma company.
Under the terms of the agreement, Lonza will construct...
Lonza Opens News Facility for ADC Payload Manufacturing Following a Tailored...
Lonza, a specialty Contract Development and Manufacturing partner for biopharmaceutical companies, inaugurated the first of two manufacturing suites for antibody-drug conjugate (ADC) drug-linker (payload)...
Navrogen and Levena to Develop Novel ADC for the Treatment of...
Biopharmaceutical company Navrogen, specialized in developing therapies for cancer and immune-related disorders, and Levena Biopharma, have agreed to collaborate in developing an antibody-drug conjugate...
5 Things You Need To Know This Week About ADCs –...
This is the second article in my series of updates about the goings on in the world of ADCs over the last two weeks....
Lonza’s Collaborative Innovation Center Helps Rethink Development and Manufacturing
A new Collaborative Innovation Center in the Haifa Life Science Park, Haifa, Israel, developed and managed by Lonza Pharma & Biotech, will acts as...
Lonza Expands Manufacturing Capacity for ADC Payloads
Lonza, a specialty contract development and manufacturing (CDMO) partner to the biopharma industry, will add new highly potent API (HPAPI) manufacturing suites at its...
Lonza acquires U.S. Manufacturing Site from Shire
Lonza is acquiring a clinical-stage mammalian manufacturing site in the United States from Dublin-based Shire.
The 58,000-square-foot (approximately 5,388-square-meter) site, located in Hayward, in...
Lonza – Celebrating 10 Years as ADC Manufacturing Pioneer
By leveraging the company's experience in biopharmaceuticals and small molecule drug process development and scale-up, Lonza has been successful in manufacturing antibody-drug conjugates, a...
